PostureCheck: A Vision-based Compensatory-posture-detection Tool for Robot-assisted Upper-limb Therapy

PostureCheck: A Vision-based Compensatory-posture-detection Tool to Enhance Performance of the BURT Upper-extremity Stroke-therapy

The overall objective of this study is to assess whether robot-assisted upper-limb group rehabilitation can be effectively delivered by using a camera-based system equipped with machine learning algorithms to track the quality of the exercise performance and provide feedback accordingly. To address this question, we plan to carry out a randomized clinical trial to compare outcomes in subjects receiving robot-assisted upper-limb rehabilitation during individual (i.e., one-on-one) sessions and in subjects receiving robot-assisted upper-limb rehabilitation during group (i.e., up to three subjects) sessions.

Study Overview

• Status: Not yet recruiting
• Conditions: Stroke
• Intervention / Treatment: Device: BURT; Device: BURT + PostureCheck

Detailed Description

The proposed study is a single-blinded randomized clinical trial to evaluate the effect of using the PostureCheck (a camera-based system equipped with machine learning algorithms to track the quality of the exercise performance) on motor gains in group and individual robot-assisted upper-limb. Study participants (stroke survivors) will be recruited at the Spaulding Rehabilitation Hospital - Boston. Subjects will be randomly assigned to one of the two different groups: individual- or group-therapy using a covariate-adaptive allocation procedure to ensure important covariates, such as baseline Fugl-Meyer Assessment of the Upper Extremity (FMA-UE) scores and proprioceptive deficits, are balanced between groups.

• Study Type: Interventional
• Enrollment (Anticipated): 42
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Gregory Schiurring, BS; Phone Number: 6179526331; Email: gschiurring@partners.org
• Study Contact Backup: Name: Catherine Adans-Dester, PhD; Phone Number: 6179526321; Email: cadans-dester@partners.org

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 80 years (Adult, Older Adult)
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

• Have had a history of ischemic cerebrovascular accident (CVA) within middle cerebral artery (MCA) or anterior cerebral artery (ACA) territory
• CVA occurred between six months and six years ago
• Moderate to severe UE impairment, FMA-UE score between 15 and 45
• Mini-Mental State Examination (MMSE) score >23 and being able to safely follow three-step commands

Exclusion Criteria:

• Advanced musculoskeletal pathology or recent fractures in the impaired UE
• Previous diagnosis of neurological diseases other than stroke
• Severe limitation of passive range of motion or spasticity (Modified Ashworth Scale for spasticity at <3 for UE muscles)
• Hemorrhagic CVA or involvement of the posterior cerebral artery
• Aphasia sufficient to limit ability to express needs or discomfort verbally or non-verbally
• Impaired visual acuity (Severe visual impairments as assessed by the NIH Stroke Scale Visual Field subscale. (score >0))
• Severe hemispatial neglect as assessed by the Line Bisection Test (score >2)
• Severely impaired trunk control (<4)
• Individuals who present with the following on the intended limb:
• Open wounds
• Fragile skin
• Under contact precautions due to an active infection
• Participation in another therapy focused on recovery of the impaired arm
• Subjects with cardiac pacemakers, electronic pumps or any other implanted medical devices, that are not US-certified
• Any Condition that would prevent safe use of the Burt system; such as proprioceptive deficits that impair the ability to process haptic or visual feedback, or unstable shoulder joint as assessed by physical examination
• Current pregnancy (self-report)
• The concern is strictly towards women who are in the 2nd or 3rd trimester and the eventuality of the arm of the BURT accidentally impacting the woman's belly. The system does have safety features (including a virtual safety wall, to keep the device away from the patient's body) but we are taking this as an extra precaution against any potential harm

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Active Comparator: Individual robot-assisted upper-limb rehabilitation; Participants randomized to this arm of the study will undergo 18 sessions of robot-assisted upper-limb rehabilitation. During the sessions, a therapist will administer one-on-one therapy (i.e. each study volunteer will work with a single therapist).	Device: BURT; Robot-assisted upper-limb individual (i.e. one-on-one) rehabilitation will be delivered using the BURT system by Barrett Technology
Experimental: Group robot-assisted upper-limb rehabilitation; Participants randomized to this arm of the study will also undergo 18 sessions of robot-assisted upper-limb rehabilitation. However, a therapist will administer the intervention as group therapy with up to three subjects participating in the session at the same time. To facilitate the deliver of the therapeutic intervention, the robot will be equipped with a camera system (called PostureCheck) designed to track the quality of the exercises.	Device: BURT + PostureCheck; Robot-assisted upper-limb group (i.e. up to three subjects) rehabilitation will be delivered using the BURT system by Barrett Technology + PostureChek (a camera-based system to track the quality of the exercises)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from baseline Fugl-Meyer Assessment - Upper Extremity (FMA-UE) at 7-8 weeks	Standard assessment of the severity of upper-limb motor impairments	Data will be collected at baseline and at 7-8 weeks

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Change from baseline Wolf Motor Function Test (WMFT) at 7-8 weeks	Standard assessment of functional limitations	Data will be collected at baseline and at 7-8 weeks
Change from baseline Motor Activity Log (MAL) at 7-8 weeks	Self-report of amount and quality of use of the stroke-affected upper limb	Data will be collected at baseline and at 7-8 weeks

Collaborators and Investigators

• Sponsor: Spaulding Rehabilitation Hospital
• Collaborators: Barrett Technology
• Investigators: Principal Investigator: Paolo Bonato, PhD, Harvard Medical School (HMS and HSDM)

Study record dates

Study Major Dates

• Study Start (Anticipated): September 1, 2023
• Primary Completion (Anticipated): September 30, 2023
• Study Completion (Anticipated): December 31, 2023

Study Registration Dates

• First Submitted: April 14, 2021
• First Submitted That Met QC Criteria: April 19, 2021
• First Posted (Actual): April 21, 2021

Study Record Updates

• Last Update Posted (Actual): May 12, 2023
• Last Update Submitted That Met QC Criteria: May 10, 2023
• Last Verified: May 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Cardiovascular Diseases; Vascular Diseases; Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Stroke
• Other Study ID Numbers: 2021P000197

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: Yes
• product manufactured in and exported from the U.S.: Yes